Tamburrini, Enrica
 Distribuzione geografica
Continente #
NA - Nord America 3.267
EU - Europa 3.236
AS - Asia 1.367
SA - Sud America 124
AF - Africa 70
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 8
Totale 8.100
Nazione #
US - Stati Uniti d'America 3.187
DE - Germania 684
IT - Italia 629
SE - Svezia 595
SG - Singapore 544
CN - Cina 398
FR - Francia 306
UA - Ucraina 261
IE - Irlanda 200
GB - Regno Unito 138
FI - Finlandia 123
ID - Indonesia 114
BR - Brasile 106
IN - India 86
RU - Federazione Russa 67
CA - Canada 60
PL - Polonia 58
TR - Turchia 42
AT - Austria 34
BE - Belgio 30
NL - Olanda 29
AU - Australia 25
IR - Iran 24
HK - Hong Kong 22
CI - Costa d'Avorio 19
SA - Arabia Saudita 19
ES - Italia 13
PH - Filippine 13
PK - Pakistan 13
CH - Svizzera 12
MX - Messico 12
RO - Romania 12
MA - Marocco 11
MY - Malesia 11
ZA - Sudafrica 10
BD - Bangladesh 9
EG - Egitto 9
CZ - Repubblica Ceca 8
PE - Perù 8
TN - Tunisia 8
VN - Vietnam 8
EU - Europa 7
GR - Grecia 7
JP - Giappone 7
IL - Israele 6
JO - Giordania 5
NP - Nepal 5
PT - Portogallo 5
BG - Bulgaria 4
CO - Colombia 4
KR - Corea 4
LT - Lituania 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
IQ - Iraq 3
KZ - Kazakistan 3
LV - Lettonia 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SD - Sudan 3
TW - Taiwan 3
UZ - Uzbekistan 3
AR - Argentina 2
CM - Camerun 2
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GL - Groenlandia 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
Totale 8.099
Città #
Chandler 740
Singapore 340
Ashburn 278
Dublin 196
Jacksonville 159
San Mateo 149
New York 136
Milan 122
Rome 122
Jakarta 113
Ann Arbor 88
Nanjing 84
Wilmington 84
Dearborn 71
Helsinki 67
Boston 55
Kraków 53
Moscow 51
Woodbridge 50
Princeton 49
Marseille 48
Chicago 47
Lawrence 43
Cattolica 40
Los Angeles 39
Boardman 34
Izmir 34
Beijing 33
Houston 33
Bremen 31
Lancaster 30
Munich 30
Seattle 30
Redwood City 29
Nuremberg 28
Nürnberg 27
Brussels 26
Nanchang 24
Norwalk 22
Ottawa 22
Vienna 21
Augusta 20
Fairfield 20
Trieste 19
Abidjan 18
London 18
Mountain View 18
Pune 16
Toronto 16
University Park 16
Amsterdam 15
Guangzhou 15
Hebei 15
Hong Kong 15
Jiaxing 14
Washington 14
North Bergen 13
Shenyang 13
Tianjin 13
Fremont 12
Hangzhou 12
Andover 11
Dammam 11
Zhengzhou 11
Zurich 11
Kish 10
Leawood 10
Oggiono 10
São Paulo 10
Changsha 9
Cuauhtémoc 9
Falls Church 9
Jinan 9
Kunming 9
San Giovanni Bianco 9
Paris 8
Sydney 8
Turin 8
Verona 8
Al Qatif 7
Frankfurt am Main 7
Hefei 7
Madrid 7
Richmond 7
San Diego 7
Cape Town 6
Detroit 6
Falkenstein 6
Timisoara 6
Amman 5
Delhi 5
Lahore 5
Latina 5
Lima 5
Melbourne 5
Monza 5
Newark 5
Phoenix 5
Rabat 5
Sacramento 5
Totale 4.281
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 439
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 230
Excretion of SARS-CoV-2 in human breast milk 146
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 142
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 133
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 131
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 126
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 126
Assessment of neurological manifestations in hospitalized patients with COVID-19 126
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 114
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 112
Migranti cinesi in gravidanza: stato sierologico relativo alle principali malattie infettive ed accesso ai servizi sanitari. L’esperienza nelle comunità di Roma e Prato 111
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 110
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 110
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 107
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 107
Cognitive reserve and neuropsychological functioning in older HIV-infected people 106
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 103
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 102
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 102
Rubella susceptibility profile in pregnant women with HIV 101
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 100
Oral lesions in HIV and HCV co-infected individuals in HAART era 100
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 99
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 98
Delivery Management in Maternal Varicella Peripartum Infection with Vulvar Lesions: A Case Report 98
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 93
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 89
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario 88
Sarilumab use in severe SARS-CoV-2 pneumonia 87
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 84
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 84
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 83
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 83
Oral lesions in HIV and HCV co-infected individuals in HAART era 81
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. 81
Residual respiratory impairment after COVID-19 pneumonia 81
Dental care and HIV-infected individuals: are they equally treated? 79
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 79
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 77
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 76
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 75
Rubella susceptibility profile in pregnant women with HIV 74
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 73
Glucose plasma levels and pregnancy outcomes in women with HIV 72
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 70
Enhancement of vaccination attitude and flu vaccination coverage among pregnant women attending birthing preparation course 70
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 70
Antiretroviral treatment in pregnancy: a six-years perspective on recent trands in prescription patterns, viral load suppression, and pregnancy outcomes. 69
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens 69
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: A multicentre case series 69
Pregnancy outcomes in women with advanced HIV infection in Italy 68
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 67
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 67
Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women 66
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 66
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001-2011 65
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 65
Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine 64
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy 64
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 64
Residual respiratory impairment after COVID-19 pneumonia 63
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 62
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 62
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 61
Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy 61
Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis 60
HCV–HIV coinfected pregnant women: data from a multicentre study in Italy 59
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy 57
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 57
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV 57
Glucose plasma levels and pregnancy outcomes in women with HIV 56
In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers 55
People Living with HIV in the COVID-19 Era: A Case Report 55
Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero 54
Risk factors for bloodstream infections in gynecological cancer 54
Neonatal Late Onset Infection with Severe Acute Respiratory Syndrome Coronavirus 2 54
Pregnancy outcomes in HIV-infected women of advanced maternal age 53
Pregnancy outcomes in women with advanced HIV infection in Italy 52
HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy 51
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients? 50
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 50
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life 47
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients 47
Off-label use of tocilizumab in patients with SARS-CoV-2 infection 47
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT 47
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report 46
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1 46
Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study 45
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 45
Body mass index and weight gain in pregnant women with HIV: a national study in Italy 44
Women Facing HIV. Key Question on Women with HIV Infection: Italian Consensus Workshop 42
Personalizing vulvar cancer workflow in COVID-19 era: a proposal from Vul.Can MDT 40
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 40
People Living with HIV in the COVID-19 Era: A Case Report 39
Declining HCV seroprevalence in pregnant women with HIV 38
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 36
COVID-19 diagnosis does not rule out other concomitant diseases 36
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women 35
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 32
Totale 7.926
Categoria #
all - tutte 41.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020202 0 0 0 0 0 0 0 0 34 44 64 60
2020/2021666 25 64 10 64 91 37 86 16 95 44 113 21
2021/2022950 106 63 22 67 35 24 37 160 37 67 135 197
2022/20232.438 252 284 214 407 236 311 107 178 255 80 87 27
2023/20241.237 46 300 42 78 64 206 83 36 37 63 121 161
2024/20251.234 39 59 229 78 203 81 116 114 315 0 0 0
Totale 8.236